Featured Research

from universities, journals, and other organizations

Molecule That 'Blocks' Key Bacterial Enzyme May Lead To New Antibiotics

Date:
June 18, 2004
Source:
Rutgers, The State University Of New Jersey
Summary:
Rutgers scientists have deciphered the complex mechanics of microcin J25 (MccJ25), a tiny, natural molecule that acts like a cork in a bottle to block a key bacterial enzyme – potentially leading to a new generation of antibiotics.

NEW BRUNSWICK/PISCATAWAY , N.J. – Rutgers scientists have deciphered the complex mechanics of microcin J25 (MccJ25), a tiny, natural molecule that acts like a cork in a bottle to block a key bacterial enzyme – potentially leading to a new generation of antibiotics.

Two teams of researchers at Rutgers, The State University of New Jersey, discovered independently that MccJ25 uniquely blocks a "tunnel" into the bacterial enzyme, RNA polymerase (RNAP). The "tunnel" is used to bring raw materials for RNA synthesis into the enzyme and to expel byproducts of RNA synthesis.

"Closing the crowded, two-way 'tunnel' starves RNAP, shuts it down and kills the bacteria," said Richard H. Ebright, a Howard Hughes Medical Institute investigator, and a professor in Rutgers' department of chemistry and chemical biology and the Waksman Institute of Microbiology. "Understanding the way in which MccJ25 works sets the stage for the development of novel antibacterial drug designs."

To understand how MccJ25 works, Ebright's group used genetic methods to test hundreds of thousands of RNAP derivatives, or variants, in order to define the binding sites for MccJ25 on RNAP. The researchers also used biophysical methods, attaching fluorescent tags to MccJ25 and to each of a dozen sites in RNAP. Using the tags, the researchers gauged the position of each bound pair in a GPS-like manner, verifying the results of the genetic work. They then used biochemical methods to find out what happened once MccJ25 binds to the RNAP.

The research team of Konstantin Severinov, an associate professor in Rutgers' department of molecular biology and biochemistry and the Waksman Institute, had been the first to demonstrate that RNAP from cells resistant to MccJ25 also showed resistance to the drug in a test tube. In their current work, these researchers used biochemical methods to characterize, in molecular detail, the mechanism of MccJ25 action. In addition, the group used sophisticated biophysical methods that revealed how MccJ25 binds to a single RNAP molecule, stopping it instantaneously.

In the June 18 issue of the journal Molecular Cell, Ebright and colleagues, and Severinov and members of his research team, describe in separate reports how each team used different experimental methods to reach the same conclusions.

"It was only last year that we solved the structure of this molecule, just 21 amino acids long, remarkable both in its size and its structure," said Ebright, a participant in the original structural studies, along with Severinov.

"A great many papers have been published on this molecule in the last year," added Severinov. "Interest in MccJ25 has really exploded."

Shaped like a lasso with its tail pulled back through the loop, MccJ25 is one of very few molecules known to have this highly stable and rigid configuration – a characteristic that may lead to applications beyond drug design.

"MccJ25's sturdy structure permits it to withstand all sorts of harsh environmental conditions," said Severinov. Because of its robustness, he added, "the [U.S.] Department of Defense is interested in the molecule as a potential bacterial decontaminating agent."

MccJ25 inhibits bacterial RNAP and kills bacteria, but it does not inhibit human RNAP and would therefore not kill a human. Ebright cautions, however, that MccJ25 has some shortcomings. It affects only E. coli and closely related bacterial species and is highly subject to developing resistance.

Rutgers researchers are already at work on overcoming these obstacles. Ebright's group has modified the molecule to produce derivatives that have a narrower resistance spectrum. The Severinov group is pursuing the same goal through a National Institutes of Health joint research program with scientists from the University of Tucuman, Argentina, who originally discovered MccJ25 in 1992.


Story Source:

The above story is based on materials provided by Rutgers, The State University Of New Jersey. Note: Materials may be edited for content and length.


Cite This Page:

Rutgers, The State University Of New Jersey. "Molecule That 'Blocks' Key Bacterial Enzyme May Lead To New Antibiotics." ScienceDaily. ScienceDaily, 18 June 2004. <www.sciencedaily.com/releases/2004/06/040618070302.htm>.
Rutgers, The State University Of New Jersey. (2004, June 18). Molecule That 'Blocks' Key Bacterial Enzyme May Lead To New Antibiotics. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2004/06/040618070302.htm
Rutgers, The State University Of New Jersey. "Molecule That 'Blocks' Key Bacterial Enzyme May Lead To New Antibiotics." ScienceDaily. www.sciencedaily.com/releases/2004/06/040618070302.htm (accessed July 24, 2014).

Share This




More Matter & Energy News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

TSA Administrator on Politics and Flight Bans

TSA Administrator on Politics and Flight Bans

AP (July 24, 2014) TSA administrator, John Pistole's took part in the Aspen Security Forum 2014, where he answered questions on lifting of the ban on flights into Israel's Tel Aviv airport and whether politics played a role in lifting the ban. (July 24) Video provided by AP
Powered by NewsLook.com
Creative Makeovers for Ugly Cellphone Towers

Creative Makeovers for Ugly Cellphone Towers

AP (July 24, 2014) Mobile phone companies and communities across the country are going to new lengths to disguise those unsightly cellphone towers. From a church bell tower to a flagpole, even a pencil, some towers are trying to make a point. (July 24) Video provided by AP
Powered by NewsLook.com
Algonquin Power Goes Activist on Its Target Gas Natural

Algonquin Power Goes Activist on Its Target Gas Natural

TheStreet (July 23, 2014) When The Deal's Amanda Levin exclusively reported that Gas Natural had been talking to potential suitors, the Ohio company responded with a flat denial, claiming its board had not talked to anyone about a possible sale. Lo and behold, Canadian utility Algonquin Power and Utilities not only had approached the company, but it did it three times. Its last offer was for $13 per share as Gas Natural's was trading at a 60-day moving average of about $12.50 per share. Now Algonquin, which has a 4.9% stake in Gas Natural, has taken its case to shareholders, calling on them to back its proposals or, possibly, a change in the target's board. Video provided by TheStreet
Powered by NewsLook.com
Robot Parking Valet Creates Stress-Free Travel

Robot Parking Valet Creates Stress-Free Travel

AP (July 23, 2014) 'Ray' the robotic parking valet at Dusseldorf Airport in Germany lets travelers to avoid the hassle of finding a parking spot before heading to the check-in desk. (July 23) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins